S. Saijyo

Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1.

T. Kudo, Y. Katayose, T. Muto, 1995, The Tohoku journal of experimental medicine.

Production of a human monoclonal antibody to a synthetic peptide by active in vivo immunization using a SCID mouse grafted with human lymphocytes.

T. Kudo, S. Habu, S. Saijyo, 1993, The Tohoku journal of experimental medicine.

A new in vitro model of specific targeting therapy of cancer: retargeting of PWM-LAK cells with bispecific antibodies greatly enhances cytotoxicity to hepatocellular carcinoma.

T. Kudo, Y. Katayose, S. Matsuno, 1996, The Tohoku journal of experimental medicine.

Specific targeting immunotherapy of cancer with bispecific antibodies.

T. Kudo, Y. Katayose, H. Yoshida, 1999, The Tohoku journal of experimental medicine.

MUC1-specific targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth.

T. Kudo, Y. Katayose, K. Fukuhara, 1996, Cancer research.

A Novel Human Monoclonal Antibody Directed to a Tumor‐associated Antigen

T. Kudo, M. Nose, Syunsuke Kobayashi, 1993, Japanese journal of cancer research : Gann.